Keyword: Prelude Therapeutics

Prelude Therapeutics

By blocking an enzyme linked to epigenetic regulation, Prelude hopes to cut off certain treatment-resistant cancers from the DNA splicing and proliferative mechanics necessary for tumor growth and survival.